Bionano Genomics, Inc. (BNGO)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 50.57M |
| Enterprise value | 35.67M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.66 |
| Price/book (mrq) | 0.61 |
| Enterprise value/revenue | 0.95 |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | 2.41 |
| 52-week change 3 | -89.32% |
| S&P500 52-week change 3 | 18.96% |
| 52-week high 3 | 6.2000 |
| 52-week low 3 | 0.5200 |
| 50-day moving average 3 | 0.7932 |
| 200-day moving average 3 | 1.1914 |
Share statistics
| Avg vol (3-month) 3 | 1.47M |
| Avg vol (10-day) 3 | 1.49M |
| Shares outstanding 5 | 80.81M |
| Implied shares outstanding 6 | 80.81M |
| Float 8 | 59.8M |
| % held by insiders 1 | 0.46% |
| % held by institutions 1 | 19.36% |
| Shares short (15 Jul 2024) 4 | 4.81M |
| Short ratio (15 Jul 2024) 4 | 2.16 |
| Short % of float (15 Jul 2024) 4 | 6.66% |
| Short % of shares outstanding (15 Jul 2024) 4 | 5.96% |
| Shares short (prior month 14 Jun 2024) 4 | 5.25M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:10 |
| Last split date 3 | 07 Aug 2023 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -304.29% |
Management effectiveness
| Return on assets (ttm) | -35.84% |
| Return on equity (ttm) | -144.33% |
Income statement
| Revenue (ttm) | 37.47M |
| Revenue per share (ttm) | 0.94 |
| Quarterly revenue growth (yoy) | 18.30% |
| Gross profit (ttm) | N/A |
| EBITDA | -115.53M |
| Net income avi to common (ttm) | -226.79M |
| Diluted EPS (ttm) | -6.1800 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 28.32M |
| Total cash per share (mrq) | 0.42 |
| Total debt (mrq) | 37.87M |
| Total debt/equity (mrq) | 45.75% |
| Current ratio (mrq) | 1.46 |
| Book value per share (mrq) | 1.44 |
Cash flow statement
| Operating cash flow (ttm) | -120.9M |
| Levered free cash flow (ttm) | -76.4M |
© 2024 Yahoo. All rights reserved.